NCT05109650View on ClinicalTrials.gov

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

March 23, 2023

Study Completion Date

February 2, 2024

Conditions
Advanced Solid Tumour
Interventions
DRUG

BAT6026

IV infusions

DRUG

BAT1308

Ⅳ infusions

Trial Locations (3)

Unknown

St George Private Hospital, Kogarah

Blacktown Cancer and Haematology Centre, Sydney

Scientia Clinical Research Limited, Sydney

Sponsors
All Listed Sponsors
lead

Bio-Thera Solutions

INDUSTRY